On the heels of closing our Series A funding, Techweek describes how Scipher Medicine is determined to get patients the right drug from day one through its diagnostic tests.

Many patients are taking drugs that don’t work for them due to the lack of understanding of their individual disease biology. Scipher’s co-founders Dr. Albert-László Barabási and Dr Joseph Loscalzo build a map of protein-protein interactions to help explain what drives diseases and how Scipher’s tests can advance precision medicine.